CLRB
Cellectar Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$25.57M
P/E Ratio
—
EPS
$-5.38
Beta
0.43
52W High
$20.59
52W Low
$2.43
50-Day MA
$2.94
200-Day MA
$3.65
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Cellectar Biosciences Inc
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development and commercialization of drugs for the treatment of cancer. The company is headquartered in Florham Park, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-22.16M |
| Operating Margin | 0.00% |
| Return on Equity | -290.40% |
| Return on Assets | -103.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.66 |
| Price-to-Book | 9.09 |
| Price-to-Sales (TTM) | 348.47 |
| EV/Revenue | 314.45 |
| EV/EBITDA | -3.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $7.99M |
| Float | $7.83M |
| % Insiders | 2.29% |
| % Institutions | 4.17% |
Historical Volatility
HV 10-Day
60.27%
HV 20-Day
83.37%
HV 30-Day
74.08%
HV 60-Day
75.59%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($10.33 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026